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eft ventricle diastolic function
a  b  s  t  r  a  c  t
Background:  An elevated  C-reactive  protein  (CRP)  level  is  associated  with  adverse  outcomes  in patients
with  acute  myocardial  infarction  (AMI).  Although  CRP  levels  have  been  shown  to  be associated  with  left
ventricular  (LV)  systolic  function  and  remodeling  in  AMI,  little  is  known  about  their  relation  to  early LV
diastolic  function.
Methods:  We retrospectively  studied  173  consecutive  patients  <75  years  of age  with  ﬁrst  ST-segment
elevation  MI  (STEMI)  that was treated  by primary  percutaneous  coronary  intervention  (PPCI).  They  had
presented  within  24  h  of  chest  pain  onset  and  their  CRP  levels  were  determined  within  6  h of  hospital
admission.  They  all underwent  echocardiography  within  3 days  of  admission  and were  stratiﬁed  by CRP
tertiles.
Results:  The  cut-off  points  for  the  CRP  tertiles  were  <2.6  mg/L,  2.6–7.9  mg/L, and >7.9  mg/L. Patients
with  higher  CRP  levels  had a  signiﬁcantly  higher  mean  mitral  inﬂow  E wave  velocity  (68  ±  16  cm/s  vs
77  ± 19  cm/s  vs 76 ± 17  cm/s;  p  = 0.02),  a  higher  E/average  e′ (8.9  ±  1.9 vs  9.8 ± 2.8  vs  10.4  ±  3.2; p =  0.02),
and  a  higher  systolic  pulmonary  artery  pressure  (27 ± 6 mmHg  vs  30 ± 8 mmHg  vs  32 ± 10  mmHg;
p  =  0.04).  Elevated  CRP  levels  were  associated  with  more  advanced  diastolic  dysfunction  than  normal  CRP
levels  (p = 0.04).  The  admission  CRP level  was  an  independent  predictor  of average  E/e′ ratio  (multivariate
analysis).
Conclusion:  Admission  CRP levels  are  associated  with  echocardiographic  parameters  of  elevated  LV  ﬁlling
pressure  in  patients  with STEMI  treated  with  PPCI.
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Ischemic injury and myocardial necrosis following an acute
yocardial infarction (AMI) incite an acute inﬂammatory response.
f the various proinﬂammatory cytokines, C-reactive protein (CRP)
as emerged as a powerful and independent predictor of heart fail-
re (HF) and long-term mortality [1–3]. Elevation of CRP levels in
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AMI  has been shown to correlate with reduced left ventricular (LV)
systolic function [2,3] and long-term LV remodeling [4,5]. While an
association between CRP and LV diastolic dysfunction has been pre-
viously reported in patients with chronic coronary artery disease
[6,7], little is known about its relation to early diastolic LV function
in the setting of an AMI.
The presence of echocardiographic parameters of diastolic
dysfunction following an AMI, especially those suggestive of ele-
vated LV ﬁlling pressures, are associated with adverse remodeling,
increased incidence of HF, and worse survival [8–11]. We  evalu-
ated the relation between CRP levels on admission and diastolic
LV function in patients presenting with ﬁrst ST-segment elevation
MI (STEMI) who  underwent successful reperfusion with primary
percutaneous coronary intervention (PPCI). We  hypothesized that
higher admission CRP levels would be associated with poorer
diastolic LV function.
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ethods and patients
We  retrospectively studied 258 consecutive patients with an
cute STEMI who had been admitted to the cardiac intensive care
nit (CICU) of the Tel-Aviv Sourasky Medical Center between May
011 and January 2013, and treated with PPCI. The baseline demo-
raphic, clinical, echocardiographic, and angiographic features test
esults were retrieved from medical ﬁles and the hospital database.
 total of 237 patients had serum CRP levels obtained immedi-
tely following primary PCI. Excluded were 43 patients older than
5 years (in order to avoid age-related diastolic dysfunction)
12], 15 patients with a previous MI,  and 3 patients who  had
evere hemodynamic instability (e.g. cardiogenic shock at admis-
ion deﬁned as persistent systolic blood pressure <90 mmHg  and
onresponsive to ﬂuid replacement, or the need for inotropes
r intra-aortic balloon pumping to maintain blood pressure
90 mmHg). Another 3 patients with a known alternative reason
or CRP elevation (2 with recent infection and 1 with connective
issue disease) were excluded, leaving a ﬁnal study population of
73 patients.
The diagnosis of STEMI in each patient was deﬁned by a typical
istory of chest pain, diagnostic electrocardiographic changes, and
erial elevation of serum cardiac biomarkers [13]. The electrocar-
iographic criterion for the diagnosis of STEMI was an ST-segment
levation of ≥1 mm in >2 adjacent leads. Symptom duration was
eﬁned as the time from symptom onset (usually chest pain or
iscomfort) to emergency room (ER) admission. The patients were
reated according to the discretion of the senior attending physician
n the CICU. PPCI was performed within 90 min of hospital admis-
ion. Blood samples for CRP were drawn in all 173 patients within
 h of admission to the emergency room. The complete blood count
arameters were measured using a Coulter STKS electronic counter
Beckman–Coulter, Hialeah, FL, USA). Wide-range CRP analysis was
erformed by the Bayer wide-range assay as previously described
14].
All patients underwent a screening echocardiographic exam-
nation within 6-72 h of CICU admission. Echocardiography was
erformed by Philips IE-33, GE, and Vivid 3 models equipped
ith S5-1 transducers (Philips Healthcare, Andover, MA,  USA). LV
iameters and interventricular septal and posterior wall width
ere measured from the parasternal short axis by means of a
-dimensional (2D) or a 2D-guided M-mode echocardiogram of
he LV at the papillary muscle level using the parasternal short-
xis view [15]. LV ejection fraction (LVEF) was calculated by the
uinones method. The 16-segment model was used for scoring
he severity of segmental wall motion abnormalities according to
he American Society of Echocardiography [16]. Early transmitral
ow velocity (E), deceleration time, and early diastolic mitral
nnular velocity (e′) were measured in the apical 4-chamber view
o provide an estimate of LV diastolic function [17]. The ratio of
eak E to peak septal, lateral, and average e′ (mitral E/e′ ratio) was
alculated from the average of at least 3 cardiac cycles. Left atrial
olume was calculated using the biplane area length method at
nd systole [18]. Cardiac output was calculated as the product of
ortic stroke volume and heart rate as demonstrated on pulse wave
oppler. Valvular regurgitation was qualitatively assessed using
olor Doppler according to the guidelines of the American Society
f Echocardiography (normal/trivial = 1, mild = 2, moderate = 3,
evere = 4) [19]. Diastolic function was assessed by integrating
easurements of the mitral inﬂow, left atrial volume, and Doppler
issue imaging of the mitral annulus using the average annulus
elocity, and classiﬁed into four categories: normal diastolic func-
ion = 0, impaired relaxation = 1, pseudo-normal = 2 and restrictive
attern = 3, based on recent guidelines [17]. Right atrial (RA)
ressure was estimated by the inferior vena cava diameter as well
s its response to inspiration as previously described [20]. Brieﬂy,iology 63 (2014) 402–408 403
expiratory and inspiratory inferior vena cava (IVC) diameters and
percent collapse were measured in subcostal views within 2 cm
of the right atrium. IVC diameter <2.1 cm that collapsed >50% with
a sniff suggested a normal RA pressure (assigned as 5 mmHg),
whereas an IVC diameter >2.1 cm that collapsed <50% with a sniff
suggested a high RA pressure (15 mmHg). In patients with IVC
diameter <2.1 cm and no collapse (<20%) with a sniff, RA pressure
was upgraded to 20 mmHg. In indeterminate cases in which the
IVC diameter and collapse did not ﬁt this paradigm, secondary
indices of elevated RA pressure were integrated. If uncertainty
remained, RA pressure was left as intermediate value of 10 mmHg.
In 122 patients with measurable tricuspid regurgitation jet on
Doppler echocardiography peak systolic pulmonary artery pres-
sure (SPAP) was estimated using the modiﬁed Bernoulli formula
(4 × TRV2max) + RAP, where TRVmax is the peak systolic tricuspid
regurgitation velocity at end expiration, and RAP is the right atrial
pressure. SPAP was  unmeasurable in the remaining 51 patients.
LV mass index was  calculated by Devereux′s formula [15]
considering the diastolic measurements of left ventricular inter-
nal diameter interventricular septal thickness and posterior wall
thickness. Relative wall thickness (RWT) was  calculated as:
2 × posterior wall thickness divided by LV diastolic diameter
[15].
All data were summarized and displayed as mean (± standard
deviation) for continuous variables and as number (percent-
age) of patients in each group for categorical variables. Patient
groups were stratiﬁed according to CRP tertiles. Since CRP dis-
played irregular distributions, we  used logarithmic transformation
which converted the distributions to normal ones for all statis-
tical procedures. Therefore, all results of CRP are expressed as
back-transformed geometrical means. The p-values were than cal-
culated using the ANOVA and the Pearson chi-square tests for the
continuous and categorical variables, respectively. Linear regres-
sion models were performed at the ENTER mode, where E/e′ was
deﬁned as the dependant variable and adjusted to age, gender,
LVEF, peak troponin, ischemia duration (deﬁned as time from
symptom onset to reperfusion), anterior MI,  coronary artery dis-
ease severity, as well as CRP. All of the analyses were considered
signiﬁcant at a 2-tailed p-value <0.05. The SPSS statistical package
was used to perform all statistical evaluations (SSPS, Chicago, IL,
USA).
Results
The study cohort included a total of 173 consecutive patients
(mean age 57 ± 9 years, range 34–75, 82% males). CRP lev-
els were measured at a median of 6.1 h after symptom onset
(25th–75th percentile 5–11 h). The median CRP value was 4.7 mg/L
(25th–75th percentile 1.84–10.87 mg/L). Baseline echocardiograms
were obtained at 1.6 ± 1.4 days following admission. Table 1
presents the clinical, laboratory, and angiographic data of patients
according to CRP tertiles. The cut-off points for the CRP tertiles
were <2.6 mg/L, 2.6–7.9 mg/L, and >7.9 mg/L. Patients with higher
CRP levels had longer symptom duration prior to ER admission
and more severe coronary artery disease. Table 2 displays the
echocardiographic parameters in groups stratiﬁed by CRP ter-
tiles. Patients with higher CRP levels had a signiﬁcantly higher
mean mitral inﬂow E wave velocity (p = 0.02), a higher septal
E/e′ (p = 0.02), a higher lateral E/e′ (p = 0.02), higher E/average e′
(p = 0.02) ratios, higher prevalence of pathologic E/e′ ratio (E/e′ lat-
eral >12 and E/e′ septal >15), and a higher SPAP (p = 0.04). There
were no signiﬁcant changes in LVEF, cardiac output, left atrial vol-
ume, and other echocardiographic parameters between the groups.
No signiﬁcant change in CRP levels was  found between those
with left atrial volume index ≤ and >32 (9.6 ± 14.9 vs 11.8 ± 9.2;
p = 0.42).
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Table 1
Clinical characteristics, angiographic ﬁndings and laboratory biomarkers by C-reactive protein (CRP) tertiles.
Variable Tertile 1
<2.6 mg/L, n = 58
Tertile 2
2.6–7.9 mg/L, n = 59
Tertile 3
>7.9 mg/L, n = 56
p-Value*
Age, years (mean ± SD) 57 ± 9 56 ± 9 56 ± 9 NS
Male  50 (86%) 48 (82%) 46 (82%) NS
Hypertension 21 (36%) 23 (39%) 17 (30%) NS
Hyperlipidemia 32 (55%) 20 (34%) 20 (36%) 0.04
Smoker 28 (48%) 43 (73%) 36(64%) 0.02
Diabetes mellitus 8 (14%) 7 (12%) 9 (16%) NS
Family history 13 (22%) 15 (25%) 13 (23%) NS
Statin  treatment 22(38%) 13(22%) 15 (26%) NS
Renin angiotensin system blockers 14 (23%) 17 (28%) 14 (25%) NS
Anterior infarct location 34 (59%) 26 (44%) 22 (39%) NS
Right  ventricular infarction 1 (1%) 2 (3%) 4 (7%) NS
Symptom duration (min) 150 (112) 200 (525) 225 (493) 0.007
Median (interquartile range)
Number of narrowed coronary arteries
1 34 (59%) 27 (46%) 20 (36%) 0.03
2  19 (32%) 17 (29%) 19 (34%) 0.02
3  5 (9%) 15 (25%) 17 (30%) 0.002
Proximal infarct-related artery narrowing 31 (53%) 31 (53%) 29 (52%) NS
Peak  troponin ng/mL (mean ± SD) 44 ± 8 62 ± 11 37 ± 7 NS
Peak  CPK, IU/l (mean ± SD) 1588 ± 205 1546 ± 204 1749 ± 233 NS
CRP,  mg/L (mean ± SD) 1.31 ± 0.74 4.97 ± 1.46 26.1 ± 22.4 <0.001
Fibrinogen, mg/dL (mean ± SD) 263 ± 54 310 ± 59 366 ± 88 <0.001
White  blood cell,103/L (mean ± SD) 11.4 ± 3.0 12.1 ± 3.5 11.4 ± 3.0 NS













* The p-values were calculated using the ANOVA and the Pearson chi-square t
on-signiﬁcance (p > 0.05).
Patients with higher CRP levels also had a more advanced
iastolic dysfunction grade (p = 0.04; Fig. 1). Admission serum
RP levels signiﬁcantly correlated with the mitral E/average
′ ratio (p < 0.001; Fig. 2). CRP emerged as an independent
redictor of E/average e′ ratio in the multivariate analysis
odel (Table 3).
able 2
chocardiographic characteristics by C-reactive protein (CRP) tertiles.
Variable Tertile 1
<2.6 mg/L, n = 58
Te
2.6
Biplane LV ejection fraction 48 ± 8 48
Wall  motion index 1.54 ± 0.4 1.5
Heart  rate (beats/min) 74 ± 10 73
Systolic blood pressure (mmHg) 135 ± 18 13
Diastolic blood pressure (mmHg) 81 ± 11 81
Cardiac output (L/min) 5.1 ± 1.2 5.1
Left  atrial volume (ml3) 62 ± 16 60
Left  atrial volume index (ml/m2) 32 ± 8 31
Mitral  inﬂow E wave (cm/s) 68 ± 16 77
Mitral  inﬂow A wave (cm/s) 65 ± 22 70
Mitral  inﬂow E/A ratio 1.15 ± 0.45 1.1
Septal  e′ (cm/s) 6.9 ± 2 6.8
E  wave velocity/septal e′ 10.3 ± 2.7 12
Lateral e′ (cm/s) 9.2 ± 2.6 9.3
E  wave velocity/lateral e′ 7.9 ± 2.3 8.7
E  wave velocity/average e′ 8.9 ± 1.9 9.8
Mitral  E deceleration time (ms) 181 ± 46 17
LV  end diastolic dimension (mm)  48 ± 7 45
LV  end systolic dimension (mm)  31 ± 7 29
Septal  thickness (mm)  11 ± 2 11
Posterior wall thickness (mm)  10 ± 2 9 ±
Relative wall thickness 0.43 ± 0.07 0.4
LV  mass index (g/m2) 101 ± 30 10
SPAP  (mmHg) 27 ± 6 30
Right  atrial pressure (mmHg) 5 ± 2 6 ±
Moderate/severe MR,  n (%) 1 (1.7%) 2 (
E/septal e′ ≥ 15, n (%) 1 (1.7%) 10
E/Lateral e′ ≥ 12, n (%) 2 (3.4%) 7 (
ata are expressed as mean ± SD. LV, left ventricle; SPAP, systolic pulmonary artery press
* The p-values were calculated using the ANOVA and the Pearson chi-square tests fo
on-signiﬁcance (p > 0.05).r the continuous and categorical variables, respectively. NS indicates two-tailed
DiscussionThis is the largest echocardiographic evaluation of the rela-
tion between CRP levels and LV function in patients with acute
STEMI treated by PPCI. Our main ﬁnding is that even a mild ele-
vation of the CRP level (>2.6 mg/L) in these STEMI patients was
rtile 2
–7.9 mg/L, n = 59
Tertile 3
>7.9 mg/L, n = 56
p-Value*
 ± 8 46 ± 8 NS
3 ± 0.4 1.61 ± 0.3 NS
 ± 11 75 ± 13 NS
9 ± 19 136 ± 20 NS
 ± 14 81 ± 12 NS
 ± 1.2 5.2 ± 1.1 NS
 ± 16 61 ± 17 NS
 ± 8 32 ± 8 NS
 ± 19 76 ± 17 0.02
 ± 21 72 ± 21 NS
9 ± 0.45 1.16 ± 0.46 NS
 ± 1.9 6.6 ± 1.8 NS
.3 ± 5.6 12.2 ± 3.7 0.02
 ± 2.7 8.5 ± 2.6 NS
 ± 2.6 9.5 ± 3.3 0.02
 ± 2.8 10.4 ± 3.2 0.02
9 ± 47 176 ± 38 NS
 ± 13 49 ± 8 NS
 ± 9 32 ± 7 NS
 ± 2 12 ± 2 NS
 3 10 ± 2 NS
3 ± 0.08 0.41 ± 0.07 NS
1 ± 37 98 ± 29 NS
 ± 8 32 ± 10 0.04
 3 6 ± 3 NS
3.3%) 2 (3.5%) NS
 (17%) 11 (20%) 0.001
11%) 10 (18%) 0.04
ure; MR,  mitral regurgitation.
r the continuous and categorical variables, respectively. NS indicates two-tailed






























sFig. 1. Correlation between admission C-reactive pro
ssociated with worsening of diastolic function and elevated LV
lling pressure, independent of LV systolic function or cardiac out-
ut. Previous studies have demonstrated the relation of early CRP
levation with LV systolic function, future HF, and mortality in AMI
atients [1–5]. Suleiman et al. demonstrated a graded association
etween CRP levels obtained within 24 h of symptom onset, wors-
ning in LV systolic function, and future HF and mortality [3]. In that
tudy, however, changes in LV systolic function as well as future
F and mortality were present among patients with moderate or
evere CRP levels (>13.5 mg/dL). In addition, fewer than half of their
atients received any reperfusion therapy (thrombolysis or PPCI).
rruda-Olson et al. reported that CRP elevation at the initial phase
f an AMI  was associated with worse diastolic dysfunction as well
s worse functional mitral regurgitation, which was  independent
f LV systolic function [21]. In that report, however, other echocar-
iographic diastolic parameters, such as mitral valve diastolic ﬂow
elocities, mitral annular velocities, SPAP, and left atrial volume
ere not evaluated. Moreover, almost half of their patients who  had
RP levels >10 mg/L had an infection within 2 weeks prior to their
ndex hospitalization with an MI  [21], thus obscuring a direct rela-
ion between CRP to diastolic dysfunction following the occurrence
f an MI.
There are now convincing data that CRP is an independent
redictor of future cardiovascular events, including cardiovascular
eath, MI,  stroke, revascularization, the development of peripheral
ascular disease, and sudden cardiac death [22–26]. Early CRP level
levation in AMI was shown to predict higher risk for future HF
evelopment, despite apparent clinical stability [3].
Although CRP level is reported to be associated with infarct size
nd the extent of myocardial necrosis [2,3] no such difference in LV
ystolic function was demonstrated between the three CRP groups.RP) tertiles and diastolic function grading (p = 0.04).
Similarly, there were no signiﬁcant differences between peak cre-
atine phosphokinase and peak troponin. The elevation of LV ﬁlling
pressure in the presence of preserved cardiac output might sug-
gest greater susceptibility of diastolic events to proinﬂammatory
activation. Early inﬂammation may  lead to acute changes in the
Frank–Starling curves of the ischemic stunned heart, resulting in
maintained cardiac output and EF at the price of increasing ﬁlling
pressures. The lack of changes in left atrial volume, a marker of pro-
longed LV ﬁlling pressure elevation, between the groups, further
suggests that the changes observed are acute rather than chronic
[2,3].
Surprisingly, E/A ratio was  not found to be signiﬁcantly different
between the CRP groups. E/A is considered a good parameter of LV
ﬁlling pressure in patients with reduced LVEF. However, it is more
challenging in patients with normal or preserved LVEF because the
status of myocardial relaxation must be clariﬁed before a reliable
assessment of diastolic function and ﬁlling pressure can be under-
taken. In fact the same E/A ratio may  underlie normal relaxation
and LV ﬁlling pressure or signiﬁcant diastolic dysfunction and ele-
vated ﬁlling pressure in patients with preserved LVEF. Although our
cohort was  composed entirely of patients with STEMI, average LVEF
was only mildly reduced (48%) and most patients (118, 68%) had
a preserved or only mildly reduced LVEF (>45%). The fact that the
majority of patients had preserved systolic function precluded esti-
mation of ﬁlling pressure just by the E/A ratio and may  have resulted
in similar E/A ratio despite entirely different ﬁlling pressures in
the CRP groups. In fact, when using the recent recommendations
for the evaluation of diastolic function by echocardiography [17]
incorporating both E/A, LA volume, and E/e′, we found a signiﬁcant
difference in diastolic dysfunction grades between the CRP groups
with a majority of patients in the lower tertile having a normal
pattern, as opposed to a majority of patients with pseudo-normal
























LV ﬁlling pressure dependent on CRP levels.
More than half of our patients had an E/e′ of 8–15. Recent
guidelines advocate the use of other supporting echocardiographic
measurements to reinforce LV ﬁlling pressure estimation whenever
Table 3
Linear regression model results.






Peak troponin 2.085 0.039
LV  ejection fraction 0.73 0.466
Anterior infarct 1.131 0. 26Fig. 2. Correlation between admission C-reac
attern in the upper tertile, suggesting that indeed higher CRP was
ssociated with higher ﬁlling pressure despite similar E/A ratio.
E/e′ ratio is only a rough estimate of LV diastolic ﬁlling pres-
ure, the differences in E/e′ ratio among CRP groups were small, and
ven in the highest CRP group the mean values for E/e′ remained
elow 15 for the septal annulus and below 12 for the lateral annu-
us which are considered the best cutoff values to diagnose elevated
lling pressure [17]. Nevertheless, the prevalence of pathologic E/e′
lateral >12,septal >15), implying elevated left atrial pressure, was
igher in the second tertile, and highest in the third tertile of CRP,
uggesting that higher CRP is associated with a tendency for patho-
ogic rise in LA pressure. Furthermore, although E/e′ is only a rough
stimate of LV diastolic ﬁlling pressure it remains the most vali-
ated non invasive parameter for its estimation, which is a main
eason that the joint diastology working group recommends that
n evaluation of ﬁlling pressure begins with e′ [17]. Several stud-
es have shown that the pulmonary capillary wedge pressure is
20 mmHg  when E/e′ is >15 (e′ from the medial annulus) or >12
e′ from lateral annuls) [27–29]. However, although E/e′ is rather
peciﬁc, it is less sensitive for increased ﬁlling pressure and many
atients with increased ﬁlling pressure have an E/e′ lower than
hose values [30].
Thus, we believe that although mean E/e′ were
elow accepted cutoff values [17] for elevated ﬁllingrotein level and E/average e′ ratio (p < 0.001).
pressures in all CRP groups, the small signiﬁcant difference in
its absolute value between groups, and the signiﬁcant increase in
prevalence of pathologic rise in both E/e′ septal and E/e′ lateral
strongly suggests that there was indeed a signiﬁcant difference inCAD extent 1.185 0.238
Ischemia duration 2.636 0.009
C-reactive protein 2.077 0.04
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/e′ is between 9 and 14 [17]. However, it has been shown that the e′
s strongly correlated with invasive measures of myocardial relax-
tion [31], and that E/e′ linearly correlates, throughout all its range
ith ﬁlling pressures in patients with a wide range of ejection frac-
ion [27–29]. Thus, we believe that although mean E/e′ were in the
ndeﬁnite range in most patients, the small signiﬁcant difference in
ts absolute value between groups strongly suggests that there was
ndeed a signiﬁcant difference in LV ﬁlling pressure dependent on
RP levels.
While there were signiﬁcant differences in E/e′ among groups,
o signiﬁcant differences were observed in e′ velocity. Although e′
elocity correlates well with invasive measures of the time con-
tant of myocardial relaxation (tau) it is not entirely governed
y relaxation [32]. The hemodynamic determinants of e′ velocity
nclude LV relaxation, preload, systolic function, and LV minimal
ressure [17,28]. For preload, although LV ﬁlling pressures have
 minimal effect on e′ in the presence of impaired LV relaxation
17,32], with normal or enhanced basal segmental LV relaxation,
s can be encountered in patients with MI  involving only the api-
al segments, preload may  inﬂuence e′ [33,34]. Furthermore, e′ is
nﬂuenced by the type of infarction. It has been shown that e′ has
ower values in the wall involved with infarction vs the contra-
ateral sites. Therefore, in patients with segmental cardiac disease,
bsolute individual values of e′ may  not entirely represent changes
n LV relaxation and are also inﬂuenced by preload and the seg-
ental nature of disease. Furthermore, an increase in E/e′ observed
n patients with elevated CRP may  represent the combined effects
f reduced relaxation or increased preload. Nevertheless, it has
een proved that even in patients with segmental systolic dys-
unction average e′ velocity can be used to correct for the effect
f LV relaxation on mitral E velocity, and that the E/e ratio is the
est predictor of LV ﬁlling pressures, suggesting that irrespective
f mechanism, elevated CRP is associated with elevated ﬁlling pres-
ure [17,34].
Our ﬁndings have several clinical implications. Measuring
erum CRP and performing comprehensive diastolic echocardiog-
aphy during the early stage of AMI  could be useful in identifying
he patients at increased risk for long-term LV remodeling, even
n the presence of preserved LV function. Oduncu et al. demon-
trated that long-term pretreatment with statins was associated
ith lower admission CRP levels in AMI  patients, as well as
ith better myocardial perfusion following PPCI [35]. Past statin
reatment had no effect on CRP levels in our cohort, however
o information was present regarding their dose and potency.
s statins are known to have pleiotropic and anti-inﬂammatory
ffects, independent of their lipid-lowering function [36,37], early
dministration of high-dose potent statins may  blunt the acute
nﬂammatory response elicited by an AMI, as indicated in the guide-
ines [13].
The present study has some limitations that warrant men-
ion. Age-related changes [12] as well as baseline diabetes and
ypertension may  result in already existing diastolic dysfunction.
earing these latter possibilities in mind, we excluded patients
lder than 75 years, whereby the mean age of our cohort was signif-
cantly lower than the mean ages of patients in previous trials that
ssessed diastolic dysfunction in AMI. CRP levels were not consecu-
ively measured throughout hospitalization, thus the magnitude of
hange and peak serum CRP over time was not determined. Finally,
o information was available on long-term outcome, including the
evelopment of HF or LV remodeling.
Overall, in our preliminary study, admission CRP levels are asso-
iated with some echocardiographic parameters of elevated LV
lling pressure in patients with STEMI treated with PPCI. Because
f the small differences in E/e′ between the CRP groups, and the
ajority of patients with E/e′ ratio between 8 and 15, our data
hould be interpreted cautiously, and larger clinical trials would
[iology 63 (2014) 402–408 407
be required to prove that CRP levels are associated with elevated
ﬁlling pressure.
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